The effect of acyclic retinoid on the metabolomic profiles of hepatocytes and hepatocellular carcinoma cells.
<h4>Background/purpose</h4>Acyclic retinoid (ACR) is a promising chemopreventive agent for hepatocellular carcinoma (HCC) that selectively inhibits the growth of HCC cells (JHH7) but not normal hepatic cells (Hc). To better understand the molecular basis of the selective anti-cancer effe...
Enregistré dans:
Auteurs principaux: | Xian-Yang Qin, Feifei Wei, Masaru Tanokura, Naoto Ishibashi, Masahito Shimizu, Hisataka Moriwaki, Soichi Kojima |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2013
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/1397b248f88a48d3ae73eb636ce2a47b |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Hepatocyte specific TIMP3 expression prevents diet dependent fatty liver disease and hepatocellular carcinoma
par: Viviana Casagrande, et autres
Publié: (2017) -
Enantiodivergence by minimal modification of an acyclic chiral secondary aminocatalyst
par: Jun Dai, et autres
Publié: (2019) -
Hepatocyte nuclear factor-1beta enhances the stemness of hepatocellular carcinoma cells through activation of the Notch pathway
par: Jing-Ni Zhu, et autres
Publié: (2017) -
NMR-based metabolomics for simultaneously evaluating multiple determinants of primary beef quality in Japanese Black cattle
par: Yoshinori Kodani, et autres
Publié: (2017) -
Retinoid Agonists in the Targeting of Heterotopic Ossification
par: Robert J. Pignolo, et autres
Publié: (2021)